Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 09-2022 | 07-2022 | 06-2022 | 04-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129 | 0 | 0 | 0 | 0 |
| Marketable Securities | 194 | 0 | 0 | 0 | 0 |
| Receivables | 98 | 0 | 0 | 0 | 0 |
| Other current assets | 14 | 0 | 0 | 0 | 0 |
| TOTAL | $435 | $0 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 14 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 364 | 0 | 0 | 0 | 0 |
| TOTAL | $377 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $826 | $0 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,481 | 0 | 0 | 0 | 0 |
| Other current liabilities | 527 | 0 | 0 | 0 | 0 |
| TOTAL | $1,932 | $0 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,932 | $0 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Common Shares | 7,111 | 0 | 0 | 0 | 0 |
| Retained earnings | -10,147 | 0 | 0 | 0 | 0 |
| Other shareholders' equity | 1,930 | 0 | 0 | 0 | 0 |
| TOTAL | $-1,106 | $0 | $0 | $0 | $0 |
| Total Liabilities And Equity | $826 | $0 | $0 | $0 | $0 |